MedPath

Lincomycin

Lincomycin Injection, USP Sterile Solution for Intramuscular and Intravenous Use

Approved
Approval ID

ebabccf4-f082-4fc0-9223-f4826dc89b13

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 18, 2023

Manufacturers
FDA

Armas Pharmaceuticals Inc.

DUNS: 098405973

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lincomycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72485-115
Application NumberANDA215082
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lincomycin
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateMay 18, 2023
FDA Product Classification

INGREDIENTS (2)

LINCOMYCIN HYDROCHLORIDEActive
Quantity: 3000 mg in 10 mL
Code: M6T05Z2B68
Classification: ACTIM
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lincomycin - FDA Drug Approval Details